Caris Life Sciences is signing up Hollywood legend Kevin Costner to break down the importance of early cancer detection—and ...

Following a monthslong interregnum at the U.S. Food and Drug Administration, the leadership pieces are again locking into ...

Bayer has won first-line approval for its tyrosine kinase inhibitor, Hyrnuo, in patients with HER2-mutant non-small cell lung ...

On Wednesday, BioMarin unveiled detailed results from the phase 3 CANOPY-HCH-3 trial assessing Voxzogo in children with hypochondroplasia (HCH), a milder form of achondroplasia, where the company ...

In keeping with its 2027 cost-cutting deadline, Merck & Co. announced another round of layoffs at its global headquarters in Rahway, New Jersey. | Merck continues sweeping staff reductions, laying off ...

In further validation of the DLL3 target pioneered by Amgen’s Imdelltra, the T-cell engager has delivered an overall survival ...

In a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, ...

Shifts in drug pricing and market access policies around the world have caused an “earthquake” that will reverberate for ...

Novo Nordisk has reported a phase 3 weight-management win for Wegovy in children, with two out of five kids no longer ...

Spying a “golden decade” beyond the branded drug industry’s looming patent cliff, Sandoz is making big bets on its biosimilar ...

They are putting AI, genomics and new models of care to work in ways that make medicine more precise, useful and accessible.

With the help of AI, AstraZeneca’s three-in-one inhaler Breztri has a new furry mascot to help it stand tall over the crowded ...